Electronic Compliance Monitoring in Opioid Substitution Treatment (EHSO)
The purpose of this study is to improve unsupervised dosing of opioid substitution medications. The aim of the study is to examine whether electronic compliance monitoring provides some advantages to patients`treatment and what kind of patients especially benefit from monitoring. We would also like to know if electronic compliance monitoring can prevent the abuse/diversion of medications and how implementing this method to wider treatment facilities succeeds.
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
|Official Title:||Electronic Compliance Monitoring in Opioid Substitution Treatment|
- The effectiveness of treatment (Treatment Outcomes Profile TOP) [ Time Frame: Every two months. ] [ Designated as safety issue: No ]Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment.
- Patients´opinions about the treatment. [ Time Frame: Once when the study phase ends (after four months). ] [ Designated as safety issue: Yes ]Questionnaire designed for this study to explore patients` opinions on the compliance monitoring and it`s effect on their treatment and abuse and/or diversion of medications.
|Study Start Date:||September 2010|
|Study Completion Date:||February 2011|
|Primary Completion Date:||February 2011 (Final data collection date for primary outcome measure)|
Experimental: Electronic compliance monitoring
Suboxone treated patients in Kuopio city area get their unsupervised Suboxone doses in electronic compliance monitoring devices during the 4 month study.
Device: Compliance monitoring with electronic device
Patients get all their unsupervised substitution medication doses in electronic monitoring devices during the study. Daily dose of the drug is possible to get from the device in given time points and in the meantime device is locked.